Skip to main content
Erschienen in: Annals of Surgical Oncology 2/2016

01.02.2016 | Breast Oncology

Comparative Study of Liposomal Bupivacaine Versus Paravertebral Block for Pain Control Following Mastectomy with Immediate Tissue Expander Reconstruction

verfasst von: Jad M. Abdelsattar, MBBS, Judy C. Boughey, MD, Aodhnait S. Fahy, BMBCh, PhD, James W. Jakub, MD, David R. Farley, MD, Tina J. Hieken, MD, Amy C. Degnim, MD, Whitney Goede, PharmD, Anita T. Mohan, MRCS, William S. Harmsen, MSc, Adam D. Niesen, MD, Nho V. Tran, MD, Karim Bakri, MBBS, Steven R. Jacobson, MD, Valerie Lemaine, MD, Michel Saint-Cyr, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Several approaches to minimize postoperative pain, nausea, and enhance recovery are available for patients undergoing mastectomy with immediate tissue expander (TE) reconstruction. We compared the effectiveness of intraoperative local infiltration of liposomal bupivacaine (LB) to preoperative paravertebral block (PVB).

Methods

We retrospectively reviewed patients who underwent mastectomy with immediate TE reconstruction between May 2012 and October 2014 and compared patients with preoperative ultrasound-guided PVB to those with intraoperative LB infiltration.

Results

Fifty-three patients (54.6 %) received LB and 44 received PVB. LB was associated with less opioid use in the recovery room (p < 0.001), fewer patients requiring antiemetics (p = 0.03), and lower day of surgery pain scores (p = 0.008). LB also was associated with longer time to first opioid use (p = 0.04). On multivariable analysis controlling for expander placement location, year of surgery, and axillary lymph node dissection (ALND), the only variable that remained statistically significant was lower opioid use in the recovery room for patients with LB (p = 0.03) and day of surgery pain scores approached significance (p = 0.05). There was no difference in the proportion of patients discharged within 36 h of surgery between the groups. Focusing on first cases of the day (where PVBs are performed in the OR) showed average time to skin incision was 15 min shorter in the LB group (p = 0.004).

Conclusions

Local infiltration of LB in patients undergoing mastectomy with immediate TE reconstruction decreases narcotic requirements in the recovery room, shortens preoperative anesthesiology time, and provides similar, if not better, perioperative pain control compared with PVB.
Literatur
1.
Zurück zum Zitat Albornoz CR, Bach PB, Mehrara BJ, et al. A paradigm shift in U.S. breast reconstruction: increasing implant rates. Plast Reconstr Surg. 2013;131:15–23.PubMedCrossRef Albornoz CR, Bach PB, Mehrara BJ, et al. A paradigm shift in U.S. breast reconstruction: increasing implant rates. Plast Reconstr Surg. 2013;131:15–23.PubMedCrossRef
2.
Zurück zum Zitat Vadivelu N, Schreck M, Lopez J, et al. Pain after mastectomy and breast reconstruction. Am Surg. 2008;74:285–96.PubMed Vadivelu N, Schreck M, Lopez J, et al. Pain after mastectomy and breast reconstruction. Am Surg. 2008;74:285–96.PubMed
3.
Zurück zum Zitat Quinn AC, Brown JH, Wallace PG, et al. Studies in postoperative sequelae. Nausea and vomiting: still a problem. Anaesthesia. 1994;49:62–5.PubMedCrossRef Quinn AC, Brown JH, Wallace PG, et al. Studies in postoperative sequelae. Nausea and vomiting: still a problem. Anaesthesia. 1994;49:62–5.PubMedCrossRef
4.
Zurück zum Zitat Layeeque R, Hochberg J, Siegel E, et al. Botulinum toxin infiltration for pain control after mastectomy and expander reconstruction. Ann Surg. 2004;240:608–13.PubMedPubMedCentral Layeeque R, Hochberg J, Siegel E, et al. Botulinum toxin infiltration for pain control after mastectomy and expander reconstruction. Ann Surg. 2004;240:608–13.PubMedPubMedCentral
5.
Zurück zum Zitat Strazisar B, Besic N, Ahcan U. Does a continuous local anaesthetic pain treatment after immediate tissue expander reconstruction in breast carcinoma patients more efficiently reduce acute postoperative pain: a prospective randomised study. World J Surg Oncol. 2014;12:16.PubMedPubMedCentralCrossRef Strazisar B, Besic N, Ahcan U. Does a continuous local anaesthetic pain treatment after immediate tissue expander reconstruction in breast carcinoma patients more efficiently reduce acute postoperative pain: a prospective randomised study. World J Surg Oncol. 2014;12:16.PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Boughey JC, Goravanchi F, Parris RN, et al. Prospective randomized trial of paravertebral block for patients undergoing breast cancer surgery. Am J Surg. 2009;198:720–5.PubMedCrossRef Boughey JC, Goravanchi F, Parris RN, et al. Prospective randomized trial of paravertebral block for patients undergoing breast cancer surgery. Am J Surg. 2009;198:720–5.PubMedCrossRef
7.
Zurück zum Zitat Coopey SB, Specht MC, Warren L, et al. Use of preoperative paravertebral block decreases length of stay in patients undergoing mastectomy plus immediate reconstruction. Ann Surg Oncol. 2013;20:1282–6.PubMedCrossRef Coopey SB, Specht MC, Warren L, et al. Use of preoperative paravertebral block decreases length of stay in patients undergoing mastectomy plus immediate reconstruction. Ann Surg Oncol. 2013;20:1282–6.PubMedCrossRef
8.
Zurück zum Zitat Fahy AS, Jakub JW, Dy BM, et al. Paravertebral blocks in patients undergoing mastectomy with or without immediate reconstruction provides improved pain control and decreased postoperative nausea and vomiting. Ann Surg Oncol. 2014;21:3284–9.PubMedCrossRef Fahy AS, Jakub JW, Dy BM, et al. Paravertebral blocks in patients undergoing mastectomy with or without immediate reconstruction provides improved pain control and decreased postoperative nausea and vomiting. Ann Surg Oncol. 2014;21:3284–9.PubMedCrossRef
9.
Zurück zum Zitat Aufforth R, Jain J, Morreale J, et al. Paravertebral blocks in breast cancer surgery: is there a difference in postoperative pain, nausea, and vomiting? Ann Surg Oncol. 2012;19:548–52.PubMedCrossRef Aufforth R, Jain J, Morreale J, et al. Paravertebral blocks in breast cancer surgery: is there a difference in postoperative pain, nausea, and vomiting? Ann Surg Oncol. 2012;19:548–52.PubMedCrossRef
10.
Zurück zum Zitat American Society of Anesthesiologists Task Force on Acute Pain Management. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology. 2012;116:248–73.CrossRef American Society of Anesthesiologists Task Force on Acute Pain Management. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology. 2012;116:248–73.CrossRef
11.
12.
Zurück zum Zitat Gorfine SR, Onel E, Patou G, et al. Bupivacaine extended-release liposome injection for prolonged postsurgical analgesia in patients undergoing hemorrhoidectomy: a multicenter, randomized, double-blind, placebo-controlled trial. Dis Colon Rectum. 2011;54:1552–9.PubMedCrossRef Gorfine SR, Onel E, Patou G, et al. Bupivacaine extended-release liposome injection for prolonged postsurgical analgesia in patients undergoing hemorrhoidectomy: a multicenter, randomized, double-blind, placebo-controlled trial. Dis Colon Rectum. 2011;54:1552–9.PubMedCrossRef
13.
Zurück zum Zitat Golf M, Daniels SE, Onel E. A phase 3, randomized, placebo-controlled trial of DepoFoam(R) bupivacaine (extended-release bupivacaine local analgesic) in bunionectomy. Adv Ther. 2011;28:776–88.PubMedCrossRef Golf M, Daniels SE, Onel E. A phase 3, randomized, placebo-controlled trial of DepoFoam(R) bupivacaine (extended-release bupivacaine local analgesic) in bunionectomy. Adv Ther. 2011;28:776–88.PubMedCrossRef
14.
Zurück zum Zitat Pacira Pharmaceuticals Inc. EXPAREL (bupivacaine liposome injectable suspension) prescribing information. Pacira Pharmaceuticals Inc.: Parsippany; 2014. Pacira Pharmaceuticals Inc. EXPAREL (bupivacaine liposome injectable suspension) prescribing information. Pacira Pharmaceuticals Inc.: Parsippany; 2014.
15.
Zurück zum Zitat American Pain Society. Principles of analgesic use in the treatment of acute pain and cancer pain. 6th edn. Glenview: American Pain Society; 2008. American Pain Society. Principles of analgesic use in the treatment of acute pain and cancer pain. 6th edn. Glenview: American Pain Society; 2008.
16.
Zurück zum Zitat Haas E, Onel E, Miller H, et al. A double-blind, randomized, active-controlled study for post-hemorrhoidectomy pain management with liposome bupivacaine, a novel local analgesic formulation. Am Surg. 2012;78:574–81.PubMed Haas E, Onel E, Miller H, et al. A double-blind, randomized, active-controlled study for post-hemorrhoidectomy pain management with liposome bupivacaine, a novel local analgesic formulation. Am Surg. 2012;78:574–81.PubMed
17.
Zurück zum Zitat Bramlett K, Onel E, Viscusi ER, et al. A randomized, double-blind, dose-ranging study comparing wound infiltration of DepoFoam bupivacaine, an extended-release LB, to bupivacaine HCl for postsurgical analgesia in total knee arthroplasty. Knee. 2012;19:530–6.PubMedCrossRef Bramlett K, Onel E, Viscusi ER, et al. A randomized, double-blind, dose-ranging study comparing wound infiltration of DepoFoam bupivacaine, an extended-release LB, to bupivacaine HCl for postsurgical analgesia in total knee arthroplasty. Knee. 2012;19:530–6.PubMedCrossRef
18.
Zurück zum Zitat Smoot JD, Bergese SD, Onel E, et al. The efficacy and safety of DepoFoam bupivacaine in patients undergoing bilateral, cosmetic, submuscular augmentation mammaplasty: a randomized, double-blind, active-control study. Aesthet Surg J. 2012;32:69–76.PubMedCrossRef Smoot JD, Bergese SD, Onel E, et al. The efficacy and safety of DepoFoam bupivacaine in patients undergoing bilateral, cosmetic, submuscular augmentation mammaplasty: a randomized, double-blind, active-control study. Aesthet Surg J. 2012;32:69–76.PubMedCrossRef
19.
Zurück zum Zitat Minkowitz HS, Onel E, Patronella CK, et al. A two-year observational study assessing the safety of DepoFoam bupivacaine after augmentation mammaplasty. Aesthet Surg J. 2012;32:186–93.PubMedCrossRef Minkowitz HS, Onel E, Patronella CK, et al. A two-year observational study assessing the safety of DepoFoam bupivacaine after augmentation mammaplasty. Aesthet Surg J. 2012;32:186–93.PubMedCrossRef
20.
Zurück zum Zitat Onel E, Miller H, Patou G, White PF. EXPAREL, a LB local analgesic, extends pain relief and decreases opioid use. Presented at the Annual Meeting of the American Society of Anesthesiologists, San Diego, CA, October 16–20, 2010. Onel E, Miller H, Patou G, White PF. EXPAREL, a LB local analgesic, extends pain relief and decreases opioid use. Presented at the Annual Meeting of the American Society of Anesthesiologists, San Diego, CA, October 16–20, 2010.
21.
Zurück zum Zitat Dasta J, Ramamoorthy S, Patou G, et al. Bupivacaine liposome injectable suspension compared with bupivacaine HCl for the reduction of opioid burden in the postsurgical setting. Curr Med Res Opin. 2012;28:1609–15.PubMedCrossRef Dasta J, Ramamoorthy S, Patou G, et al. Bupivacaine liposome injectable suspension compared with bupivacaine HCl for the reduction of opioid burden in the postsurgical setting. Curr Med Res Opin. 2012;28:1609–15.PubMedCrossRef
Metadaten
Titel
Comparative Study of Liposomal Bupivacaine Versus Paravertebral Block for Pain Control Following Mastectomy with Immediate Tissue Expander Reconstruction
verfasst von
Jad M. Abdelsattar, MBBS
Judy C. Boughey, MD
Aodhnait S. Fahy, BMBCh, PhD
James W. Jakub, MD
David R. Farley, MD
Tina J. Hieken, MD
Amy C. Degnim, MD
Whitney Goede, PharmD
Anita T. Mohan, MRCS
William S. Harmsen, MSc
Adam D. Niesen, MD
Nho V. Tran, MD
Karim Bakri, MBBS
Steven R. Jacobson, MD
Valerie Lemaine, MD
Michel Saint-Cyr, MD
Publikationsdatum
01.02.2016
Verlag
Springer US
Erschienen in
Annals of Surgical Oncology / Ausgabe 2/2016
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-015-4833-4

Weitere Artikel der Ausgabe 2/2016

Annals of Surgical Oncology 2/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.